This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n7http://dx.doi.org/10.1039/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q60230370
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel article by Robert Trondl et al published 4 April 2014 in Chemical Science im April 2014 veröffentlichter wissenschaftlicher Artikel наукова стаття, опублікована у квітні 2014 article scientifique publié en 2014
p:P577
wds:Q60230370-E871725F-3C22-418C-8B40-3AFD5B25188D
wdt:P577
2014-04-04T00:00:00Z
p:P2093
wds:Q60230370-EE163180-DB7D-43E5-A7E9-04CEF98E17BD wds:Q60230370-D84E0FC7-4B72-4CE0-8789-8D60D500944F wds:Q60230370-95D3E3B5-36B2-41BF-9DEF-65CCABBD565E wds:Q60230370-39EA9344-2917-4852-918C-B04EB9485F31
wdt:P2093
Bernhard K. Keppler Walter Berger Robert Trondl Christian R. Kowol
rdfs:label
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
skos:prefLabel
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
schema:name
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
p:P50
wds:Q60230370-10BD0F57-AF76-42DF-9BD2-5358BD2566AA wds:Q60230370-1DE5C9EE-7AB5-4678-95E0-C62BEF96789C
wdt:P50
wd:Q42173445 wd:Q38800373
p:P1476
wds:Q60230370-608DD54A-57FC-438E-B763-9FBEF69D46D6
wdt:P1476
NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
p:P304
wds:Q60230370-3972E939-6098-4605-8ED9-EAFAA073BCA2
wdt:P304
2925-2932
p:P31
wds:Q60230370-8F4C8665-7E8A-4F4D-84B8-5191E20682CC
wdt:P31
wd:Q13442814
p:P1433
wds:Q60230370-A2565263-3D2C-4C4A-9640-34FAD53FA777
wdt:P1433
wd:Q2962267
p:P433
wds:Q60230370-239EA58B-2B8E-4BBB-9064-4D0510263311
p:P478
wds:Q60230370-39CAACE1-D09C-4301-A7F2-7E57877830C6
wdt:P433
8
wdt:P478
5
p:P356
wds:Q60230370-907AD0B9-22FE-4886-A995-2C624B1711D7
wdtn:P356
n7:C3SC53243G
wdt:P356
10.1039/C3SC53243G